Literature DB >> 11052215

Pathophysiology of the basal ganglia in Parkinson's disease.

J A Obeso1, M C Rodríguez-Oroz, M Rodríguez, J L Lanciego, J Artieda, N Gonzalo, C W Olanow.   

Abstract

Insight into the organization of the basal ganglia in the normal, parkinsonian and L-dopa-induced dyskinesia states is critical for the development of newer and more effective therapies for Parkinson's disease. We believe that the basal ganglia can no longer be thought of as a unidirectional linear system that transfers information based solely on a firing-rate code. Rather, we propose that the basal ganglia is a highly organized network, with operational characteristics that simulate a non-linear dynamic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052215     DOI: 10.1016/s1471-1931(00)00028-8

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  178 in total

1.  Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription.

Authors:  B Liss; O Franz; S Sewing; R Bruns; H Neuhoff; J Roeper
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 2.  Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management.

Authors:  Teus van Laar
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Neuropsychological function in manganese alloy plant workers.

Authors:  Rita Bast-Pettersen; Dag G Ellingsen; Siri M Hetland; Yngvar Thomassen
Journal:  Int Arch Occup Environ Health       Date:  2004-03-13       Impact factor: 3.015

Review 4.  Striatal mechanisms underlying movement, reinforcement, and punishment.

Authors:  Alexxai V Kravitz; Anatol C Kreitzer
Journal:  Physiology (Bethesda)       Date:  2012-06

5.  Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.

Authors:  F Suárez; Q Zhao; D T Monaghan; D E Jane; S Jones; A J Gibb
Journal:  Eur J Neurosci       Date:  2010-07-06       Impact factor: 3.386

6.  Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease.

Authors:  O K Sujith; Carol Lane
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

Review 7.  The executioners sing a new song: killer caspases activate microglia.

Authors:  J L Venero; M A Burguillos; P Brundin; B Joseph
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

Review 8.  Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia.

Authors:  Annalisa Pinna; Marcello Serra; Micaela Morelli; Nicola Simola
Journal:  J Neural Transm (Vienna)       Date:  2018-02-02       Impact factor: 3.575

9.  Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat.

Authors:  Nicholas MacInnes; Marcus J Messenger; Susan Duty
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

10.  Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.

Authors:  Puneet Bagga; Rachelle Crescenzi; Guruprasad Krishnamoorthy; Gaurav Verma; Ravi Prakash Reddy Nanga; Damodar Reddy; Joel Greenberg; John A Detre; Hari Hariharan; Ravinder Reddy
Journal:  J Neurochem       Date:  2016-10-16       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.